IJJ CORPORATION (OTCMKTS:IJJP0) signed a partnership deal with American Seed & Oil Company. It is a subsidiary firm of Algae International Group Inc (OTCMKTS:ALGA). The partnership agreement is finalized to construct a residential treatment facility for U.S Veterans suffering from Post Traumatic Stress Disorder, commonly known as PTSD. The treatment protocol will cover, but will not require vaporizing or smoking marijuana. It intends to run an educational program that will teach residents about sustainable marijuana cultivation skills.
The residential treatment facility
The concept of residential treatment centre for U.S. Veterans was proposed by the American Seed & Oil Company. It is founded and owned and run by U.S. Veterans. It approached IJJ CORPORATION (OTCMKTS:IJJP0) based on its success with the partnerships to expand pot cultivation facilities in Canada.
The management view
Clifford Pope, the Chairman and President of IJJ Corporation, said that as a wartime U.S. veteran, he is extremely enthusiastic about residential facility plan and would be committed to implement it successfully. Pope said IJJ CORPORATION (OTCMKTS:IJJP0) is the right firm to look after the development plan of residential treatment facility. It successfully completed expansion of Michigan Plant Technologies and Canadian facilities in past.
Steven Rash, the CEO of American Seed & Oil, said that the company has identified land, received university scholarship and selected professional social work expert team for the project. IJJ CORPORATION (OTCMKTS:IJJP0) project funding strategy seems to be the right fit for their plan. The company had devoted more than one year to finalize every single detail of the plan.
American Seed & Oil and IJJ CORPORATION (OTCMKTS:IJJP0) is not the only one expressing their support regarding medical benefits of pot in the treatment of PTSD. Even The Colorado Department of Public Health & Environment granted a $2 million amount to the non-profit organization MAPS for their planned research of marijuana for symptoms of PTSD in 76 U.S. veterans.